NIKKEI 225
38,617.10 -329.83 (-0.85%) HANG SENG
19,195.60 -25.02 (-0.13%) CRUDE OIL
78.16 -0.50 (-0.64%) GOLD FUTURES
2,394.00 -31.90 (-1.31%) DOW
39,845.63 -27.36 (-0.07%) Bitcoin GBP
55,133.23 +405.30 (+0.74%)
Viatris Inc. (VIA.DE)
| Previous close | 10.10 |
| Open | 10.10 |
| Bid | 10.13 x N/A |
| Ask | 10.18 x N/A |
| Day's range | 10.09 - 10.18 |
| 52-week range | 8.28 - 12.60 |
| Volume | |
| Avg. volume | 2,776 |
| Market cap | 12.062B |
| Beta (5Y monthly) | 1.13 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | -0.05 |
| Earnings date | 05 Aug 2024 - 09 Aug 2024 |
| Forward dividend & yield | 0.45 (4.42%) |
| Ex-dividend date | 23 May 2024 |
| 1y target est | N/A |
GuruFocus.comViatris Inc's Dividend Analysis
Viatris Inc (NASDAQ:VTRS) recently announced a dividend of $0.12 per share, payable on 2024-06-14, with the ex-dividend date set for 2024-05-23. As investors look forward to this upcoming payment, the spotlight also shines on the company's dividend history, yield, and growth rates. Using the data from GuruFocus, let's look into Viatris Inc's dividend performance and assess its sustainability.
PR NewswireViatris Publishes 2023 Sustainability Report: Building Sustainable Access at Scale
Viatris Inc. (NASDAQ: VTRS), a global healthcare company, today published its 2023 Sustainability Report: Building Sustainable Access at Scale. The report highlights its actions and initiatives across multiple areas of focus in support of the Company's efforts to continue to be a model for sustainable access to medicine and to make a difference in the communities it serves.
ZacksTheravance (TBPH) Q1 Earnings Top, Revenues Match Estimates
Theravance's (TBPH) first-quarter 2024 earnings beat estimates while revenues meet the same.
